Cell Therapy

Rare retinal diseases like MacTel often lead to the development of abnormal blood vessels and the permanent loss of clear central vision. This challenging medical reality has prompted Alcon, a global leader in eye care, to enter into a definitive agreement to acquire Neurotech Pharmaceuticals for

Dr. Hans-Peter Kiem’s early medical training at the University of Ulm laid the groundwork for his future breakthroughs in the regenerative potential of hematopoietic stem cells. This fascination with the building blocks of the blood system eventually propelled him to the forefront of translational

The long-standing exodus of Australian medical breakthroughs to international production lines has finally met a formidable domestic rival with the official unveiling of the ENTRI facility in Brisbane. For decades, the local biotechnology sector struggled with a critical infrastructure deficit that

Manufacturing failures can occur if patients receive lymphodepleting agents like bendamustine too close to the collection of their therapeutic T cells. This biological reality creates a high-stakes environment for oncologists managing relapsed/refractory multiple myeloma, where the timing of every

Engineering a synthetic alternative to natural nerve grafts requires a complex balance of structural durability, nutrient diffusion, and precise biological signaling. When peripheral nerves are severed, the internal fibers often lose their way, leading to permanent loss of sensation and motor

Clinical data from Phase I trials indicate that patients receiving XS411 experienced an average increase of five hours of daily functional time within six months of treatment. This significant therapeutic achievement represents a transformative shift for individuals living with Parkinson’s disease,